Location & dates EMBL Heidelberg, Germany 5 - 10 May 2019
Deadlines Registration closed Abstract submission closed
Organiser_IBIS

Coronavirus information for participants

The onsite course and conference programme at EMBL has been paused until the end of June 2020.


We aim to continue offering our advanced training for the scientific community however we safely can. While some events have been cancelled, many have been rescheduled for a later date and others will be delivered as virtual events.


Registration is open for onsite courses and conferences starting after 1 July and for the virtual events. All registration fees for any events which don’t take place due to the COVID-19 disruption are fully refundable.


More information for participants of events at EMBL Heidelberg can be found here.

Programme

Got something to say? Tweet it! #EMBLBioIron 

Day 1 - Sunday 5 May 2019
(Educational Day, Keynote Lecture and Welcome Reception)
TimeSpeakerLocation
Introductory Course: Iron Essentials for Clinicians and Scientists
Coordinated by Jodie Babitt, Hal Drakesmith and Ioav Cabantchik
08:00 - 09:00 Arrival and Registration for Educational Day
with light refreshments
ATC Registration Desk
09:00 - 18:00

Introductory Course: Iron Essentials for Clinicians and Scientists
Coordinated by Jodie Babitt, Ioav Cabantchik and Hal Drakesmith

ATC Auditorium
09:00 - 09:05 Introductory Remarks 
Ioav Cabantchik, President IBIS - Hebrew University of Jerusalem, Israel
ATC Auditorium
09:05 - 12:30 Session 1: Basic Properties and Methodologies 
Chairs: Greg Anderson and Robert Fleming 
ATC Auditorium
09:05 - 09:45 BioIron: Origin, chemical properties and evolution
Kostas Pantopoulos - McGill University, Canada
09:45 - 10:30 Iron transport proteins: Gateways of cellular and systemic iron homeostasis 
Mitchell Knutson - University of Florida, United States of America
10:30 - 11:00 Coffee Break  ATC Auditorium Foyer
11:00 - 12:30 Session 1: Basic Properties and Methodologies (continued)
Chairs: Greg Anderson and Robert Fleming 
ATC Auditorium
11:00 - 11:45 Mechanisms controlling cellular iron homeostasis in mammals 
Rick Eisenstein - University of Wisconsin-Madison, United States of America
11:45 - 12:30 Systemic iron homeostasis 
Jodie Babitt - Massachusetts General Hospital, Harvard Medical School, United States of America
12:30 - 13:30 Lunch EMBL Canteen
13:30 - 15:30 Session 2: Genetic and Acquired Iron Disorders
Chairs: Clara Camaschella and Günter Weiss
ATC Auditorium
13:30 - 14:00 Genetic diseases causing iron deficiency and iron overload: Two faces of the same coin 
Laura Silvestri - San Raffaele Scientific Institute, Italy
14:00 - 14:30 Erythropoiesis and iron metabolism: Crosstalk, implications, and therapeutic options in iron loading anemias 
Yelena Ginzburg - Icahn School of Medicine at Mount Sinai, United States of America
14:30 - 15:30 Iron in cancer, infection, kidney and liver diseases: Innocent bystander or therapeutic target? 
Igor Theurl and Heinz Zoller - Medical University of Innsbruck, Austria
15:30 - 16:00 Coffee Break ATC Auditorium Foyer
16:00 - 17:30 Session 3: Global Issues
Chairs: Domenico Girelli and Dorine Swinkels
ATC Auditorium
16:00 - 16:45 The pathophysiology and diagnosis of iron deficiency and anaemia in populations and patients 
Sant-Rayn Pasricha - Walter and Eliza Hall Institute, Australia
16:45 - 17:30 Nutritional (dietary) and "functional" deficiencies in the first and third world 
Michael Zimmermann - ETH Zürich, Switzerland
17:30 - 18:00 Session 4: The Future of BioIron
Chair: Hal Drakesmith
ATC Auditorium
17:30 - 18:00 Open questions in basic and clinical iron research
"It is hard to make predictions, especially about the future." -- Yogi Berra

Tomas Ganz and Elizabeta Nemeth - University of California, Los Angeles, United States of America
17:30 - 18:30 Arrival and Registration for Keynote Lecture and Welcome Reception
with light refreshment
ATC Registration Desk
18:30 - 19:30 Keynote Lecture: Analyzing microbiomes in us and on our planet
Peer Bork - EMBL Heidelberg, Germany
ATC Auditorium
19:30 - 21:30 Welcome Reception
with nibbles and refreshments
ATC Auditorium Foyer
Day 2 - Monday 6 May 2019
TimeSpeakerLocation
08:00 - 08:45 Arrival and Registration
with light refreshments
ATC Registration Desk
08:45 - 09:00 Welcome Remarks 
by organisers Ioav Cabantchik - Hebrew University of Jerusalem, Israel
Matthias Hentze - EMBL Heidelberg, Germany
Martina Muckenthaler - University of Heidelberg, Germany

ATC Auditorium

(streamed to ATC Courtyard Room A & B)
09:00 - 12:30 Plenary 1: Cell Biology of Iron Metabolism 
Chairs: Bruno Galy and Matthias Hentze

ATC Auditorium

(streamed to ATC Courtyard Room A & B)
09:00 - 09:30 Mechanisms of ferroptosis
Marcus Conrad - Helmholtz Zentrum München, Germany
09:30 - 09:45 Mechanisms, pathways and regulation of mammalian ferritin secretion
Lior Spektor - Technion - Israel Institute of Technology, Israel
09:45 - 10:00 Novel mechanistic insights into the regulation of BMP-SMAD pathway and hepcidin expression by FKBP12
Alessandro Dulja -  San Raffaele Scientific Institute, Italy
10:00 - 10:15 A novel role for peroxisomal proteins in iron homeostasis
Nathan Subramaniam - Queensland University of Technology, Australia
10:15 - 10:30 A systems genetics approach to identify genes and pathways involved in liver iron overload and pathology
Brie Fuqua - University of California, Los Angeles, United States of America
10:30 - 11:00 Coffee Break ATC Foyer
11:00 - 12:30 Plenary 1: Cell Biology of Iron Metabolism (continued)
Chairs: Mitchell Knutson and Marie-Paule Roth

ATC Auditorium

(streamed to ATC Courtyard Room A & B)
11:00 - 11:30 Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling
Martina Rauner - TU Dresden Medical Center, Germany
11:30 - 12:00 Regulation of transferrin receptor via S-acylation
Aurelio Teleman - German Cancer Research Center, Germany
12:00 - 12:15 Ncoa4-mediated ferritinophagy maintains murine erythropoiesis via cell autonomous and non-autonomous mechanisms
Joseph Mancias - Dana-Farber Cancer Institute, United States of America
12:15 - 12:30

PCBP1-mediated iron binding and delivery in the cytosol: mechanisms and impacts
Caroline Philpott -  National Institutes of Health, United States of America

12:30 - 14:00 Lunch ATC Auditorium Foyer
14:00 - 15:30 Concurrent Session 1: Iron Deficiency in Cancer Patients: A Clinical Perspective
Chairs: Max Gassmann and Andrea Steinbicker
ATC Auditorium
14:00 - 14:20 Iron deficiency in cancer patients: An emerging issue but difficult to define
Domenico Girelli - University of Verona, Italy
14:20 - 14:40 Management of anemia and iron deficiency in cancer patients: What guidelines say?
Manuel Muñoz - University of Málaga, Spain
14:40 - 15:00 Perioperative anemia and iron deficiency in oncological surgery
Donat Spahn - University Hospital Zürich, Switzerland
15:00 - 15:30 Round Table Discussion ATC Auditorium
14:00 - 15:30 Concurrent Session 2: Erythropoiesis and Iron 
Chairs: Robert Fleming and Antonella Nai
Large Operon
14:00 - 14:30 Gene therapy to cure hemoglobinopathies
Marina Cavazzana - Hôpital Necker - Enfants Malades, France

14:30 - 14:45

Combining Tfr2-haploinsufficiency with TMPRSS6-antisense oligonucleotides strongly ameliorates the hematological phenotype of thalassemic mice
Antonella Nai - San Raffaele Scientific Institute, Italy
14:45 - 15:00 The regulation of ferroportin and iron regulatory protein 2 on erythropoiesis
Deliang Zhang - National Institutes of Health, United States of America
15:00 - 15:15 The role of glutathione peroxidase 4 and vitamin E in reticulocyte maturation and iron homeostasis
Georg W. Bornkamm - Helmholtz Zentrum München, Germany
15:15 - 15:30 AMPK regulates the expression of the Fe-S cluster assembly enzyme (ISCU) and ALAS2, modulating cellular iron metabolism and increasing hemoglobin synthesis
Ping La - Children's Hospital of Philadelphia, United States of America
14:00 - 15:30 Concurrent Session 3: Heme Physiology and Pathophysiology 
Chairs: Iqbal Hamza and Emanuela Tolosano
ATC Courtyard Room A & B
14:00 - 14:15 The safe coordinated trafficking of heme and iron after heme-hemopexin endocytosis requires copper for cell homeostasis
Ann Smith - University of Missouri, United States of America
14:15 - 14:30 Heme cytotoxicity in the brain: Microglia polarization and neuronal damage
Illyane Lima - NOVA University Lisbon, Portugal
14:30 - 14:45 Iron deposition associated to vascular damage and hemolysis causes senescence and fibrosis
Mate Maus - IRB Barcelona, Barcelona Institute of Science and Technology, Spain
14:45 - 15:00 Modulating heme biosynthesis alters Toxoplasma sensitivity to antimalarials
Clare Harding - University of Glasgow, United Kingdom
15:00 - 15:15 Metabolic adaptation in colorectal cancer: Heme export is required for the modulation of the tricarboxylic acid cycle
Veronica Fiorito - University of Turin, Italy
15:15 - 15:30 Heme synthesis/Heme export axis as a novel regulator of cellular oxidative metabolism
Emanuela Tolosano - University of Turin, Italy
15:30 - 16:00 Coffee Break ATC Auditorium Foyer
16:00 - 17:30 Concurrent Session 4: Infection and Inflammation 
Chairs: Caroline Philpott and Günter Weiss
ATC Auditorium
16:00 - 16:15 Non-transferrin-bound iron in hematopoietic stem cell transplanted patients serves as iron source for Aspergillus fumigatus outgrowth
Verena Petzer - Medical University of Innsbruck, Austria
16:15 - 16:30 Reduction in erythrocyte life span as a key component of mycobacteria induced anemia
Maria Salomé Gomes - University of Porto, Portugal
16:30 - 16:45 The role of TNFa and IFNg in anemia of inflammation, immunity and stress erythropoiesis
Stefano Rivella - Children's Hospital of Philadelphia, United States of America
16:45 - 17:00 Hepcidin-mediated hypoferremic response to acute inflammation requires a threshold of Bmp6/Hjv/Smad signaling
Edouard Charlebois - McGill University, Canada
17:00 - 17:15 Hemolysis and intracellular heme confer protection against anti-CD40-triggered macrophage activation syndrome and vaso-occlusive inflammatory liver disease
Giada Ingoglia - University of Zürich, Switzerland
17:15 - 17:30 Anemia in infants at age 10-24 weeks predicts reduced long-term efficacy of diphtheria vaccine: a 2-year prospective observational study in rural Kenya
Nicole Stoffel - ETH Zürich, Switzerland
16:00 - 17:30 Concurrent Session 5: Liver Iron-Sensing and Control of the Hepcidin/Ferroportin Regulatory System
Chairs: Laura Silvestri and Jodie Babitt
Large Operon
16:00 - 16:30 New modes of hepcidin regulation
Hal Drakesmith - University of Oxford, United Kingdom
16:30 - 16:45 Endothelial Bmp2 knockout exacerbates hemochromatosis in Hfe knockout mice but not Bmp6 knockout mice
Xia Xiao - Massachusetts General Hospital, Harvard Medical School, United States of America
16:45 - 17:00 The hemochromatosis proteins are dispensable for acute BMP2-mediated hepcidin upregulation in mice
Alessia Pagani - San Raffaele Scientific Institute, Italy
17:00 - 17:15 MyD88 regulates the expression of SMAD4 and the iron regulatory hormone hepcidin
Macha Samba Mondonga - University of Montreal, Canada
17:15 - 17:30 Spatial zonation of hepcidin in the liver is patterned by testosterone
Hélène Coppin - INSERM, France
16:00 - 17:30 Concurrent Session 6: Iron and Neurodegeneration 
Chairs: Ashley Bush and Raffaella Gozzelino
ATC Courtyard Room A & B
16:00 - 16:30 Is ferroptosis, a newly characterized iron-dependent form of cell death, a clue for neuroprotection in Parkinson's disease?
David Devos - University of Lille, France
16:30 - 16:45 Evidence for communication between systemic iron status and cerebrospinal fluid:  Clinical implications for therapeutic strategy
James Connor - Pennyslvania State University, United States of America
16:45 - 17:00 Mitochondrial ferritin attenuates ferroptosis and ER-stress induced apoptosis in an experimental model of ischemic stroke
Peina Wang - Hebei Normal University, China
17:00 - 17:15 How and why does iron storage fail with age?
Gawain McColl - University of Melbourne, Australia
17:15 - 17:30 Changes in gut microbiota: An early event in Parkinson’s disease
Raffaella Gozzelino - NOVA University of Lisbon, Portugal
16:00 - 17:30 Concurrent Session 7: Iron Deficiency Disorders and Their Treatment
Chairs: Diego Moretti and Heinz Zoller
Small Operon
16:00 - 16:15 The effect of genetic variation in TMPRSS6 (SNP rs855791) on iron metabolism and oral iron absorption: a stable iron isotope study in Taiwanese women
Sung-Nan Pei - Chia-Yi Chang Gung Memorial Hospital, Taiwan
16:15 - 16:30 Tmprss6-/- mice show plasma FGF23 elevation that is influenced by Fgf23 gene dosage
Xiuqi Li - Yale School of Medicine, United States of America
16:30 - 16:45 Generation and development of KY1070, a fully human anti-BMP6 antibody for treatment of Anemia of Chronic Disease
Volker Germaschewski - Kymab, United Kingdom
16:45 - 17:00 Iron deficiency and a genetic risk score derived from GWAS are associated with Restless Legs Syndrome and its severity in 20,000 blood donors
David J. Roberts - University of Oxford, United Kingdom
17:00 - 17:15 Novel formulations to fortify rice with iron: Evidence and public health potential
Diego Moretti - Swiss Distance University of Applied Sciences, Switzerland
17:15 - 17:30 Fecal microbiota as a biomarker to predict the tissue iron accumulation in intestine epithelial cells and liver
Liwei Xie - Guangdong Institute of Microbiology, China
17:30 - 18:00

Meet the Master 
Interview with Maria de Sousa
with refreshments
Presenter: Ioav Cabantchik

ATC Auditorium Foyer Stage
18:00 - 19:30 Dinner  EMBL Canteen
19:30 - 20:30

Open Debate: Controversies in Bioiron
Topic: Intravenous Iron Supplementation in Chronic Cardiac Failure
Moderator: Tomas Ganz
In Favor: Iain Macdougall - King's College Hospital, United Kingdom
Against: Hossein Ardehali - Northwestern University, United States of America

ATC Courtyard A & B
19:30 - 22:00 Poster Session I (odd numbers)
with drinks and snacks
ATC Helix A & B
Day 3 - Tuesday 7 May 2019
TimeSpeakerLocation
07:45 - 08:45

Meet the Expert 1: Gene Therapy for Iron Disorders
Stefano Rivella - University of Pennsylvania, United States of America

Concurrent sessions. Students / trainees only - Space is limited, pre-registration essential.

ATC Helix Seminar Room A
07:45 - 08:45

Meet the Expert 2: Tracing the Intracellular Dynamics of Iron and Heme
Iqbal Hamza - University of Maryland, United States of America

Concurrent sessions. Students / trainees only - Space is limited, pre-registration essential.

ATC Helix Seminar Room B
09:00 - 12:30 Plenary 2: Disorders of Iron Metabolism
Chairs: Clara Camaschella and Antonello Pietrangelo
ATC Auditorium

(streamed to ATC Courtyard Room A & B)

09:00 - 09:30 The battle for iron between pathogens, the host, and the microbiota in the inflamed gut
Manuela Raffatellu -  University of California, San Diego, United States of America
09:30 - 10:00 Ferritinophagy and cell cycle control
Francesca Carlomagno - University of Naples Federico II, Italy
10:00 - 10:15 The natural history of ferroportin Ddsease – first results of the international, multicenter non-HFE registry
Benedikt Schaefer - Medical University of Innsbruck, Austria
10:15 - 10:30 New insights into the molecular mechanisms underlying the pro-atherosclerotic effect of non-transferrin-bound iron
Francesca Vinchi - New York Blood Center, United States of America
10:30 - 11:00 Coffee Break ATC Auditorium Foyer
11:00 - 12:30 Plenary 2: Disorders of Iron Metabolism (continued)
Chairs: Tomas Ganz and Stefano Rivella
ATC Auditorium

(streamed to ATC Courtyard Room A & B)

11:00 - 11:30 Treating leukemia with oxidative ferrotherapy
Monica Guzman - Cornell University, United States of America
11:30 - 12:00 Iron, ferroptosis, aging and Alzheimer’s disease
Ashley Bush - The Florey Institute of Neuroscience and Mental Health, Australia
12:00 - 12:15 Differential effects of IRP1 deficiency versus HIF-2a IRE deletion on postnatal erythropoiesis in mice
Rick Eisenstein - University of Wisconsin-Madison, United States of America
12:15 - 12:30 Absence of iron-responsive element-binding protein 2 causes a novel neurodegenerative syndrome
Nunziata Maio - National Institutes of Health, United States of America
12:30 Packed Lunch  ATC Auditorium Foyer
From 12:30 Free Afternoon
19:00 - 20:30 Drinks Reception with Live Music Blue Note Jazz Trio
Ticketed event. Heidelberg Castle
Heidelberg Castle
Day 4 - Wednesday 8 May 2019
TimeSpeakerLocation
07:45 - 08:45

Meet the Expert 3: Translating Biologic Discoveries to Clinical Practice
Tomas Ganz - University of California, Los Angeles, United States of America
Elizabeta Nemeth - University of California, Los Angeles, United States of America

Concurrent sessions. Students / trainees only - Space is limited, pre-registration essential
ATC Helix Seminar Room A
07:45 - 08:45

Meet the Expert 4: Biophysical Approaches to Iron Speciation in Cells and Organ Development
Robert Hider - King's College London, United Kingdom
Paul Lindahl - Texas A&M University, United States of America

Concurrent sessions. Students / trainees only - Space is limited, pre-registration essential.
ATC Helix Seminar Room B
09:00 - 12:30

Plenary 3: Biology of Iron-Sulfur Proteins
Chairs: Roland Lill* and Ioav Cabantchik

(* COST Action 15133 "The Biogenesis of Iron-sulfur Proteins: from Cellular Biology to Molecular Aspects (FeSBioNet))

ATC Auditorium

(streamed to ATC Courtyard Room A & B)
09:00 - 09:30 Iron homeostasis regulates facultative heterochromatin assembly in adaptive genome control
Shiv Grewal - National Institutes of Health, United States of America
09:30 - 10:00 Irp2 regulates insulin production through iron-mediated Cdkal1-catalyzed tRNA modification
Elisabeth Leibold - University of Utah, United States of America
10:00 - 10:30 Friedreich ataxia: role of frataxin and pathophysiological consequences
Hélène Puccio* - INSERM, France
10:30 - 11:00 Coffee Break ATC Auditorium Foyer
11:00 - 12:30

Plenary 3: Biology of Iron-Sulfur Proteins (continued)
Chairs: Tracey Rouault and Caroline Enns

(* COST Action 15133 "The Biogenesis of Iron-sulfur Proteins: from Cellular Biology to Molecular Aspects (FeSBioNet))

ATC Auditorium

(streamed to ATC Courtyard Room A & B)
11:00 - 11:30 Cytosolic and nuclear iron-sulfur protein assembly
Oliver Stehling* - Philipps University of Marburg, Germany
11:30 - 12:00 The lability of the NEET proteins' iron sulphur cluster: Biomedical implication
Rachel Nechushtai* - Hebrew University of Jerusalem, Israel
12:00 - 12:15 Fe-S cluster biogenesis in DNA repair proteins: Structural studies of the CIA machinery
Susanne Kassube - Friedrich Miescher Institute for Biomedical Research, Switzerland
12:15 - 12:30 Dimeric ferrochelatase bridges ABCB7 and ABCB10 homodimers in an architecturally defined molecular complex required for heme biosynthesis
Nunziata Maio - National Institutes of Health, United States of America
12:30 - 14:15 Lunch  ATC Auditorium Foyer
14:15 - 15:15 Concurrent Session 8: Cardiovascular Disease 
Chairs: Hossein Ardehali and Samira Lakhal-Littleton
ATC Auditorium
14:15 - 14:30 Unexpected differences in cardiac iron metabolism and survival in Hepcidin-ko and FpnC326S mice
Sandro Altamura - Heidelberg University, Germany
14:30 - 14:45 Role of mTOR-TTP Pathway in cardiac response to iron deficiency
Hossein Ardehali - Northwestern University, United States of America
14:45 - 15:00 Smooth muscle cell iron retention contributes to the pathology of abdominal aortic aneurysm
Paul Loick - University of Oxford, United Kingdom
15:00 - 15:15 Interfering with endothelial heme metabolism to control the angiogenic process
Sara Petrillo - University of Turin, Italy
14:15 - 15:15 Concurrent Session 9: Macrophage and Iron Metabolism 
Chairs: Igor Theurl and Francesca Vinchi 
Large Operon
14:15 - 14:30 Systemic dysfunction in Lysinuric Protein Intolerance drives immune complications
Susanna Bodoy - IRB Barcelona, Spain
14:30 - 14:45 Myeloid heavy chain ferritin mitigates ischemic acute kidney injury
Laurence Black - University of Alabama at Birmingham, United States of America
14:45 - 15:00 The macrophage iron phenotype – a novel target in cancer therapy?
Christina Mertens - Heidelberg University Hospital, Germany
15:00 - 15:15

Transfusion-induced impairment of macrophage responses is partially restored by the iron chelator deferasirox
Francesca Vinchi - New York Blood Center, United States of America

14:15 - 15:15

Concurrent Session 10: Iron Biology and Disease 
Chairs: Sonia Levi and Mayka Sanchez 
ATC Courtyard Room A & B
14:15 - 14:30 Induction of erythroferrone in healthy humans by microdose recombinant erythropoietin or high altitude exposure
Elena Gammella - University of Milan, Italy
14:30 - 14:45 Iron Regulatory Protein 1 requires glycogen branching enzyme and mitoNEET to remain functional as an iron-regulatory holo-form
Kirst King-Jones - University of Alberta, Canada
14:45 - 15:00 TGFß regulates BMP2 in liver sinusoidal endothelial cells: A possible link between chronic liver disease and iron overload
Silvia Colucci - Heidelberg University, Germany
15:00 - 15:15 PIGA germline mutations may cause a novel subtype of hereditary hemochromatosis
Lena Muckenthaler - Heidelberg University, Germany
15:15 - 16:00 Coffee Break ATC Auditorium Foyer
16:00 - 17:30 Concurrent Session 11: Iron Overload, Iron Chelation and Targeted Therapies 
Chairs: Robert Hider and Dorine Swinkels
ATC Auditorium
16:00 - 16:15 A new orally active iron chelator: CN128
Robert Hider - King's College London, United Kingdom
16:15 - 16:30 Applications of nanotechnology to the delivery of iron chelators
Greg Anderson - QIMR Berghofer Medical Research Institute, Australia
16:30 - 16:45

Orally-delivered ginger nanoparticle-derived lipid vectors target functional Dmt1 siRNAs to duodenal enterocytes and Mitigate Iron Loading in Hepcidin KO Mice
Xiaoyu Wang - University of Florida, United States of America

16:45 - 17:00

Gastrointestinal iron excretion and reversal of iron excess in a mouse model of inherited iron excess
Thomas Bartnikas - Brown University, United States of America

17:00 - 17:15 Novel third-generation ferrostatins protect against acute iron poisoning-induced organ injury
Samya Van Coillie -  VIB-UGent, Belgium
17:15 - 17:30 Double knockout of ZIP14 and ZIP8 in mice reveals novel roles for ZIP8 in tissue iron accumulation in iron overload
Mitchell Knutson - University of Florida, United States of America
16:00 - 17:30 Concurrent Session 12: Cancer and Ferroptosis
Chairs: Marcus Conrad and Monica Guzman 
Large Operon
16:00 - 16:30 MYCN mediates cysteine addiction and sensitizes to ferroptosis
Frank Westermann - German Cancer Research Center, Germany
16:30 - 16:45 Iron induces cell death and synergizes with anti-androgen therapy in prostate cancer pre-clinical models
Alessandro Campanella - San Raffaele Scientific Institute, Italy
16:45 - 17:00 Amyloid precursor protein (APP) supports tumorigenesis by counteracting iron-mediated oxidative stress and p38MAPK-dependent DNA damage
Vivek Venkataramani - University Medical Center Göttingen, Germany
17:00 - 17:15 NCOA4 expression regulates ferritin accumulation and has differential effects on RSL3- and erastin-induced ferroptosis in HeLa cells
Magdalena Gryzik - University of Brescia, Italy
17:15 - 17:30 Pro-tumor characteristics of macrophage-derived lipocalin-2 (Lcn-2) are determined by its iron-load
Michaela Jung - Goethe-University Frankfurt, Germany
16:00 - 17:30 Concurrent Session 13: Tissue-Specific Regulation of Iron Metabolism
Chairs: Yelena Ginzburg and Katarzyna Mleczko-Sanecka
ATC Courtyard Room A & B
16:00 - 16:15 Intracellular iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension through endothelin-1
Samira Lakhal-Littleton - University of Oxford, United Kingdom
16:15 - 16:30 Mitoferrin 1/2 Deficiency in Type 2 Alveolar epithelial cells aggravates pulmonary fibrosis
Suzanne M. Cloonan - Weill Cornell Medical College, United States of America
16:30 - 16:45 Iron regulatory protein 2 (IRP2) mediates resistive breathing-induced pulmonary inflammation
Kostas Pantopoulos - McGill University, Canada
16:45 - 17:00 A novel role for iron regulatory proteins in hematopoiesis
Michael Bonadonna German Cancer Research Center, Germany
17:00 - 17:15 The role of hepatic transferrin in erythropoiesis
Yingying Yu - Zhejiang University School of Medicine, China
17:15 - 17:30 The iron-sensing receptor Tfr2 regulates osteoclastogenesis
Ulrike Baschant - TU Dresden, Germany
17:30 - 18:00 Meet the Master
Interview with Lawrie Powell
with refreshments
Presenter: Greg Anderson
ATC Auditorium Foyer Stage
18:00 - 19:30 Dinner EMBL Canteen
19:30 - 22:00 Poster Session II (even numbers)
with drinks and snacks
ATC Helix A & B
Day 5 - Thursday 9 May 2019
TimeSpeakerLocation
07:45 - 08:45

Meet the Expert 5: DNA Biomarkers of Iron Disorders 
Domenico Girelli - University of Verona, Italy
Dorine Swinkels - Radboud University, The Netherlands

Students / trainees only - Space is limited, pre-registration essential. 
ATC Helix Seminar Room A
09:00 - 11:00 Plenary 4: Presidential Plenary Session with Top-Scoring Abstracts
Chairs: Ioav Cabantchik and Martina Muckenthaler

ATC Auditorium

(streamed to ATC Courtyard Room A & B)
09:00 - 09:20 Iron powers adaptive immune responses to immunisations and influenza virus
Joe Frost - University of Oxford, United Kingdom
09:20 - 09:40 A novel iron chaperone complex delivers iron to the cytosolic [2Fe-2S] cluster distribution system
Sarju Patel - National Institutes of Health, United States of America
09:40 - 10:00

IRP mediated iron homeostasis in gut epithelial cells limits intestinal tumorigenesis
Bruno Galy - German Cancer Research Center, Germany

10:00 - 10:20 Steroyl-CoA Desaturase 1 protects ovarian cancer cells from ferroptotic cell death
Suzy Torti - University of Connecticut Health Center, United States of America
10:20 - 10:40 Delineating heme transport using HRG1-deficient mouse models
Iqbal Hamza - University of Maryland, United States of America
10:40 - 11:00 Ablation of hepatocyte Smad1, Smad5 and Smad8 causes severe tissue iron loading and liver fibrosis in mice
Chia-Yu Wang - Massachusetts General Hospital, United States of America
11:00 - 11:30 Coffee Break ATC Auditorium Foyer
11:30 - 13:00 Concurrent Session 14: Hereditary Hemochromatosis 
Chairs: Pierre Brissot and Graça Porto
ATC Auditorium
11:30 - 12:00 Ancient genomics and the origins of the European genome
Daniel Bradley - Trinity College Dublin, Ireland 
12:00 - 12:15 The structure-function analysis of ferroportin 1 (FPN1) gating residues sheds new light on the pathogenic mechanisms involved in haemochromatosis type 4A (HC 4A)
Marlène Le Tertre -University Hospital Brest , France
12:15 - 12:30 Iron overload associated osteoporosis could be favored by a low level of hepcidin and/or by an alteration of Mn or Mo metabolisms
Olivier Loréal - INSERM, France
12:30 - 12:45 Penetrance of hereditary hemochromatosis mutations in 450,000 people of European ancestry
David Melzer - University of Exeter Medical School, United Kingdom
12:45 - 13:00

Hemochromatosis: A lower illness with higher implications. A rare opportunity of following the natural history of an age related disease
Graça Porto - University of Porto, Portugal

11:30 - 13:15 Concurrent Session 15: Therapeutic Approaches 
Chairs: Kostas Pantopoulos and Michael Zimmermann
Large Operon
11:30 - 11:45 The evolution of intravenous iron therapy
Carlo Gaillard - University of Utrecht, The Netherlands
11:45 - 12:00 Evaluation of the intrinsic Hepcidin Idx™ to detect iron deficiency (Id) in adolescents and young adults
Mark Fleming - Boston Children's Hospital, United States of America
12:00 - 12:15 Oral iron therapy in predialysis Chronic Kidney Disease (CKD) patients has no adverse effects on the gut microbiome and circulating uremic toxin concentrations
Dorine Swinkels - Radboud University Medical Center, The Netherlands
12:15 - 12:30 Nanostructured iron compounds for nutrition: Isotope studies in DMT1-knockout mice and Thai women
Hans Winkler - ETH Zürich, Switzerland
12:30 - 12:45 An antisense Oligonucleotide (IONIS-TMPRSS6-LRX) targeting transmembrane protease, Serine 6 (TMPRSS6) induces hepcidin and reduces serum iron and transferrin saturation in healthy volunteers
Y Paul Goldberg - Ionis Pharmaceuticals, United States of America
12:45 - 13:00 SLN124, a GalNAc-siRNA conjugate targeting TMPRSS6, for the treatment of iron overload and Iieffective erythropoiesis such as in beta thalassemia
Ute Schaeper - Silence Therapeutics GmbH, Germany
13:00 - 13:15 Characterization of hepcidin and microglia in an Alzheimer mouse model
Andreas Popp - Abbvie Deutschland, Germany
11:30 - 13:00 Concurrent Session 16: Iron and Development 
Chairs: Elizabeta Nemeth and Nathan Subramaniam
ATC Courtyard Room A & B
11:30 - 11:45 Universal applicable serum hepcidin pediatric reference ranges: set point relative to body iron parameters changes during human growth and development
Albertine Donker - Radboud University Medical Center, The Netherlands
11:45 - 12:00 Iron transport to the fetus is controlled by a ‘Selfish’ placenta
Veena Sangkhae - University of California, Los Angeles, United States of America
12:00 - 12:15 Maternal iron excess and inflammation during pregnancy synergize to cause embryotoxicity
Allison Fisher -  University of California, Los Angeles, United States of America
12:15 - 12:30 Iron and n-3 fatty acid depletion, alone and in combination, during early development provoke anxiety, hedonic and social dysfunction in rats
Jeannine Baumgartner - ETH Zürich, Switzerland
12:30 - 12:45 Behavioral effects of excess ferrous sulfate or ferrous bisglycinate chelate supplementation on suckling rat pups
Shasta McMillen - University of California, Davis, United States of America
12:45 - 13:00 The regulation of cellular heme metabolism is crucial for deurodevelopment
Deborah Chiabrando - University of Turin, Italy
13:00 - 14:30 Lunch ATC Auditorium Foyer
14:30 - 18:30 Free Time
14:30 - 15:30 Business Meeting
for members of the International BioIron Society
ATC Auditorium
15:30 - 16:30 Hemochromatosis Nomenclature Meeting ATC Courtyard Room A & B
16:30 - 18:00 Joint European Federation of Associations of Patients with Haemochromatosis (EFAPH) and Haemochromatosis International (HI) Annual General Meeting Large Operon
18:30 - 19:30 Social Hour
with refreshments
ATC Auditorium Foyer
19:30 - 21:30 Farewell Dinner with Award Ceremony EMBL Canteen
21:30 - 01:00 Party with Live Bands
Opening Act: The Iron-Balls
Headliner: The Wright Thing
ATC Auditorium Foyer
Day 6 - Friday 10 May 2019
(International Haemochromatosis Patients Meeting)
TimeSpeakerLocation
08:30 - 09:30

What's New

  • What is new in HH? Report from the BioIron Meeting 2019 (Prof. Mayka Sanchez) (15 min)
  • Innovative approaches in HH-therapy (Prof. Pierre Brissot) (15 min)
  • Update of the EuroBloodNet activities (Prof. Graça Porto) (15 min)
  • Discussion of three previous presentations (15 min)
ATC Courtyard A
09:30 - 10:15 The Impact of Research on Diagnosis and Therapy of Haemochromatosis Patients (Prof. Paul Adams)
ATC Courtyard A
10:15 - 10:35 Coffee Break Foyer Courtyard
10:35 - 11:20

Haemochromatosis Arthropathy (HARI Group)

  • Update on HARI’s projects (Dr. Patrick Kiely) (20 min)
  • Outcome of ankle joint replacement (Dr.Axel Braner ) (10 min)
  • Questions to previous two presentations (15 min)
ATC Courtyard A
11:20 - 11:35 Haemochromatosis Nomenclature Update (Prof. Pierre Brissot)
ATC Courtyard A
11:35 - 12:20 Review of 2018 by EFAPH and HI Member Associations (F. Courtois – D. Prince)
ATC Courtyard A
12:20 - 13:20 Lunch EMBL Canteen
13:20 - 16:00

Updates and Future Projects

  • The future of EFAPH / HI: Towards a closer partnership (Howard Don, Ketil Toska) (20 min)
  • World Haemochromatosis Week 2019 (June Saturday 1st – Sunday 9th) and 2020?  (15 min)
  • Future projects continued & agreed actions (45 min) (Dianne Prince, Ketil Toska)
  • Other issues
ATC Courtyard A
16:00 - 16:30 Concluding Remarks (New presidents of EFAPH and HI)
ATC Courtyard A